Abstract: Novel, stable formulations of bupropion hydrochloride are provided which will maintain at least 80% of initial bupropion hydrochloride potency after one year. Methods of inhibiting degradation of bupropion hydrochloride and methods of preparing stable formulations of bupropion hydrochloride are also provided.
Type:
Grant
Filed:
April 2, 2001
Date of Patent:
November 19, 2002
Assignee:
Clonmel Healthcare, Ltd.
Inventors:
Prakash Shriram Kulkarni, Bharat Bhogilal Shah, Amitava Maitra, Joseph Michael DeVito